<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>Latest Medical Technology from Bio-Medicine.Org</title>
<link>http://www.bio-medicine.org/medicine-technology-1/</link>
<description>Latest Medical Technology lists</description>
<language>en-us</language>
<copyright>Copyright 2012. Bio-Medicine All Rights Reserved.</copyright>
<item>
<title><![CDATA[Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Ibrutinib-Phase-2-Study-Results-in-Patients-with-Mantle-Cell-Lymphoma-Published-in-The-New-England-Journal-of-Medicine-33976-1/</link>
<pubDate>Wed, 19 Jun 2013 07:04:34 MST</pubDate>
<description><![CDATA[SUNNYVALE, Calif.  , June 19, 2013 /- Pharmacyclics, Inc. (the "Company") (Nasdaq:   PCYC ) today announced that  The New England Journal of Medicine  ( NEJM ) published results of a Phase 2 study evaluating the investigational oral Bruton's tyrosine kinase (BTK) inhibitor ibrutinib in patients with relapsed/refractory mantle cell lymphoma (MCL) online. These data suggested ibruti... ]]></description>
</item>
<item>
<title><![CDATA[Haemonetics Announces Next Steps in Manufacturing Transformation]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Haemonetics-Announces-Next-Steps-in-Manufacturing-Transformation-33975-1/</link>
<pubDate>Wed, 19 Jun 2013 03:22:24 MST</pubDate>
<description><![CDATA[BRAINTREE, Mass.  , June 19, 2013 /-&#160;Haemonetics Corporation (NYSE:   HAE ) today announced several important developments in the pursuit of its previously announced manufacturing transformation.&#160;    (Logo:  http://photos.prnewswire.com/prnh/20120206/NE47232LOGO  )     Haemonetics has selected Sanmina Corporation (NASDAQ:   SANM ) for the future production of medical dev... ]]></description>
</item>
<item>
<title><![CDATA[Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Dr--Robert-Bernstein-in-NY-Magazines-Best-Doctors-Issue-for-14th-Consecutive-Year-33974-1/</link>
<pubDate>Wed, 19 Jun 2013 03:22:17 MST</pubDate>
<description><![CDATA[NEW YORK  , June 19, 2013 /PRNewswire-iReach/ --  Robert M. Bernstein, M.D., F.A.A.D. , a pioneer of modern hair transplant procedures and founder of Bernstein Medical &#8211; Center for Hair Restoration, was included in the 'Best Doctors' issue of New York Magazine for the fourteenth consecutive year.   (Photo:&#160;  http://photos.prnewswire.com/prnh/20130619/CG34629 )    Dr. Bernstein earne... ]]></description>
</item>
<item>
<title><![CDATA[Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Allscripts-Congratulates-Dr--Davis-Lee--Winner-of-the-2013-Association-of-Medical-Directors-of-Information-Systems--28AMDIS-29-Award-33973-1/</link>
<pubDate>Wed, 19 Jun 2013 03:22:10 MST</pubDate>
<description><![CDATA[CHICAGO  , June 19, 2013 /- Dr.  Davis Lee , CMIO for PIH Health has been named one of four recipients of the 2013 AMDIS Award, a prestigious recognition saluting excellence and outstanding achievement in applied medical informatics.    "On behalf of Allscripts, I'd like to congratulate Dr. Lee for his recognition in leadership, innovation and continuous efforts to improve patient... ]]></description>
</item>
<item>
<title><![CDATA[Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Echo-Therapeutics-Announces-Closing-of-Public-Offering-of-Common-Stock-And-Full-Exercise-of-Over-Allotment-Option-by-the-Underwriter-33972-1/</link>
<pubDate>Wed, 19 Jun 2013 03:22:03 MST</pubDate>
<description><![CDATA[PHILADELPHIA  , June 19, 2013 /-&#160;Echo Therapeutics, Inc. (Nasdaq:   ECTE ), a company developing its needle-free Symphony &#174;  CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced the closing of a previously announced underwritten public offering of 4,025,000 shares of its common stock and the full exercise of the over-allotment opti... ]]></description>
</item>
<item>
<title><![CDATA[AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/AAHomecare-and-Maryland-DME-Provider-Take-Medicare-Agency-to-Court-Over-Competitive-Bidding-Program-33971-1/</link>
<pubDate>Wed, 19 Jun 2013 03:21:55 MST</pubDate>
<description><![CDATA[WASHINGTON  , June 19, 2013 /PRNewswire-USNewswire/ -- The American Association for Homecare (AAHomecare), along with a home medical equipment provider from   Maryland  , announced today the filing of a  lawsuit  in U.S. District Court in   Washington, D.C.  , asking that the scheduled July 1 expansion of the Medicare competitive bidding program (CBP) for durable medical equipment (DME) be sto... ]]></description>
</item>
<item>
<title><![CDATA[Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Lilly-Issues-Alert-for-Illegal-Scams-Involving-Fraudulent-Checks-and-Online-Job-Requests-33970-1/</link>
<pubDate>Wed, 19 Jun 2013 03:21:47 MST</pubDate>
<description><![CDATA[INDIANAPOLIS  , June 19, 2013 /- Eli Lilly and Company (NYSE:   LLY ) today issued an alert about two illegal scams, purportedly using the name of the company and/or its subsidiary Elanco Animal Health, that are actively targeting the public through postal mail solicitations and job-seekers through online dialogue. Lilly and Elanco have no connection to any foreign lottery organiz... ]]></description>
</item>
<item>
<title><![CDATA[Amgen Award For Science Teaching Excellence Honors Outstanding Teachers]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Amgen-Award-For-Science-Teaching-Excellence-Honors-Outstanding-Teachers-33969-1/</link>
<pubDate>Wed, 19 Jun 2013 03:21:40 MST</pubDate>
<description><![CDATA[THOUSAND OAKS, Calif.  , June 19, 2013 /- Amgen is pleased to announce the nine science teachers in   the United States  ,   Canada   and   Puerto Rico   who are this year's recipients of the Amgen Award for Science Teaching Excellence (AASTE). Now in its 21st year, the award recognizes extraordinary teachers at the kindergarten through 12th grade level who have an outstanding abi... ]]></description>
</item>
<item>
<title><![CDATA[Partnerships, Licensing, Investments and M&amp;A Deals and Trends for May 2013 in Pharmaceuticals]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Partnerships--Licensing--Investments-and-M-26amp-3BA-Deals-and-Trends-for-May-2013-in-Pharmaceuticals-33968-1/</link>
<pubDate>Wed, 19 Jun 2013 03:21:32 MST</pubDate>
<description><![CDATA[NEW YORK  , June 19, 2013 /-  Reportlinker.com  announces that a new market research report is available in its catalogue:    Partnerships, Licensing, Investments and M&amp;A Deals and Trends for May 2013 in Pharmaceuticals   http://www.reportlinker.com/p0925641/Partnerships-Licensing-Investments-and-MA-Deals-and-Trends-for-May-2013-in-Pharmaceuticals.html#utm_source=prnewswire&am... ]]></description>
</item>
<item>
<title><![CDATA[Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Ibrutinib-Study-Results-in-Patients-with-Relapsed-Refractory-Chronic-Lymphocytic-Leukemia-Published-in-The-New-England-Journal-of-Medicine-33967-1/</link>
<pubDate>Wed, 19 Jun 2013 03:21:20 MST</pubDate>
<description><![CDATA[SUNNYVALE, Calif.  , June 19, 2013 /- Pharmacyclics, Inc. (the "Company") (Nasdaq:   PCYC ) today announced that  The New England Journal of Medicine  ( NEJM ) published results online of a Phase 1b/2 study evaluating the investigational oral Bruton's tyrosine kinase (BTK) inhibitor ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocy... ]]></description>
</item>
<item>
<title><![CDATA[Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Ellen-MacArthur-Foundation-presenterar-Philips-som-global-partner-vid-det-konstituerande-internationella-toppm-F6tet-om-cirkul-E4r-ekonomi-33966-1/</link>
<pubDate>Wed, 19 Jun 2013 03:21:09 MST</pubDate>
<description><![CDATA[LONDON  , June 19, 2013 /-   Ellen MacArthur Foundation meddelade i dag att Philips under de kommande tre &#229;ren kommer att vara en partner f&#246;r att hj&#228;lpa till att p&#229;skynda &#246;verg&#229;ngen till cirkul&#228;r ekonomi.   Efter stiftelsens framg&#229;ngsrika partnerskap med Renault, BT/Cisco (som samarbetar), Kingfisher och National Grid, kommer Philips att ans... ]]></description>
</item>
<item>
<title><![CDATA[NextDocs and Novella to Present on eTMF at DIA 2013]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/NextDocs-and-Novella-to-Present-on-eTMF-at-DIA-2013-33965-1/</link>
<pubDate>Wed, 19 Jun 2013 10:09:24 MST</pubDate>
<description><![CDATA[CONSHOHOCKEN, Pa.  , June 19, 2013 /-&#160; NextDocs  announced today that it will co-present with Novella, a full service clinical research organization, at  DIA 2013 , the Drug Information Association annual meeting and conference.&#160; The companies will present case studies that explore best practices for making the transition from paper trial master file to electronic trial... ]]></description>
</item>
<item>
<title><![CDATA[New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/New-Data-on-Islet-Autoantibodies-in-Young-Children-Defines-Early-Type-1-Diabetes-Development-33964-1/</link>
<pubDate>Wed, 19 Jun 2013 08:51:23 MST</pubDate>
<description><![CDATA[NEW YORK  , June 19, 2013 /PRNewswire-USNewswire/ -- A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M&#252;nchen,   Germany  , is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes (T1D), highlighting the importance of pre-diabetes research into possible preventions for the disease. The... ]]></description>
</item>
<item>
<title><![CDATA[Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Three-Lessons-Learned-to-Reduce-Alarm-Fatigue-and-Improve-Alarm-Management-and-Patient-Safety-in-Hospitals-33963-1/</link>
<pubDate>Wed, 19 Jun 2013 06:56:30 MST</pubDate>
<description><![CDATA[CHICAGO  , June 19, 2013 /- The Physician-Patient Alliance for Health &amp; Safety recently released three lessons to reduce alarm fatigue.   The need to urgently address this issue has been emphasized by  The Joint Commission in its Sentinel Event Alert #50 , "Medical device alarm safety in hospitals." According to The Joint Commission Sentinel Event Alert database, between Janua... ]]></description>
</item>
<item>
<title><![CDATA[Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Caradigm-Provisioning-Helps-Healthcare-Organizations-Improve-Clinical-Efficiency--Manage-Risk-33962-1/</link>
<pubDate>Wed, 19 Jun 2013 06:39:21 MST</pubDate>
<description><![CDATA[BELLEVUE, Wash.  , June 19, 2013 /-&#160;Caradigm today announced the availability of Provisioning version 4.0, a solution designed to help healthcare organizations efficiently manage clinician access to applications and data while supporting their compliance with data privacy regulations. The new release of Provisioning represents a milestone in the delivery of advanced role life... ]]></description>
</item>
<item>
<title><![CDATA[Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Finesse-Solutions-Launches-Next-Generation-SmartGlass-3L-Bioreactors-for-Cell-Culture-and-Fermentation-33961-1/</link>
<pubDate>Wed, 19 Jun 2013 06:39:13 MST</pubDate>
<description><![CDATA[SANTA CLARA, Calif.  , June 19, 2013 /-&#160;Finesse Solutions, Inc, a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of its new SmartGlass&#8482; autoclavable 3L glass bioreactors for upstream cell culture and fermentation.&#160; The 3L glass vessels are the first in a new product family of Finesse bioreactors and ar... ]]></description>
</item>
<item>
<title><![CDATA[BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/BioCision-Announces-Two-New-U-S--Patents-for-Thermo-Conductive-Products-that-Standardize-Sample-Handling-in-Laboratory-Research-33960-1/</link>
<pubDate>Wed, 19 Jun 2013 06:39:05 MST</pubDate>
<description><![CDATA[LARKSPUR, Calif.  , June 19, 2013 /-&#160; BioCision , a leader in advanced products to improve sample standardization and handling in many areas of medical and scientific research, announced today the issuance of new patents by the U.S. Patent Office that apply to two of the company's thermo-conductive products developed to standardize sample handling to ensure the consistency of... ]]></description>
</item>
<item>
<title><![CDATA[Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 &amp; Toca FC in Patients with Recurrent Brain Cancer]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Voices-Against-Brain-Cancer-Awards-Grant-to-Tocagen-to-Support-Investigation-of-Toca-511--26amp-3B-Toca-FC-in-Patients-with-Recurrent-Brain-Cancer-33959-1/</link>
<pubDate>Wed, 19 Jun 2013 06:38:55 MST</pubDate>
<description><![CDATA[NEW YORK  , June 19, 2013 /-&#160; Voices Against Brain Cancer  (VABC), a not-for-profit organization dedicated to finding a cure for brain cancer, today announced that it has awarded Tocagen Inc. ( www.tocagen.com ) a grant to support the clinical investigation of Toca 511 &amp; Toca FC in patients diagnosed with a recurrent high grade glioma brain cancer (Grade 3 or Grade 4).&#1... ]]></description>
</item>
<item>
<title><![CDATA[U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/U-S--and-European-Rheumatologists-Agree-That-a-Therapys-Induction-of-Remission-is-One-of-the-Attributes-That-Most-Influences-Their-Prescribing-Decisio-33958-1/</link>
<pubDate>Wed, 19 Jun 2013 06:38:47 MST</pubDate>
<description><![CDATA[BURLINGTON, Mass.  , June 19, 2013 /-&#160;Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of rheumatoid arthritis, the majority of surveyed U.S. and European rheumatologists cite a therapy's induction of remission as one of the attributes that most influences their prescribing decis... ]]></description>
</item>
<item>
<title><![CDATA[Drug Patent Watch]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Drug-Patent-Watch-33957-1/</link>
<pubDate>Wed, 19 Jun 2013 06:38:39 MST</pubDate>
<description><![CDATA[MUMBAI, India  , June 19, 2013 /-   Bharat Book Bureau has recently added DrugPatentWatch to its extensive list of Online Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf )   &#160;&#160;&#160;&#160; (Logo: http://photos.prnewswire.com/prnh/20130128/590935)     DrugPatentWatch provides comprehensive information on pharmaceutical, drug patents and their expirations.... ]]></description>
</item>
</channel>
</rss>